Factors and Prognosis of Obstructive Pyelonephritis Patients
- Conditions
- PyelonephritisPrognostic
- Registration Number
- NCT06299215
- Lead Sponsor
- Assistance Publique - Hôpitaux de Paris
- Brief Summary
Acute obstructive pyelonephritis is a condition with a high risk of complications and may require admission to the intensive care unit.
Most of the available data on this condition comes from small, retrospective, single-centre series.
To date, no large-scale study has examined the factors associated with the prognosis of patients admitted to intensive care for acute obstructive pyelonephritis.
The aim of this study is to describe the population and prognosis of patients admitted to the intensive care unit for the management of acute obstructive pyelonephritis, and to identify factors associated with a poor prognosis in these patients.
- Detailed Description
The retrospective and multicenter study consists of a retrospective and pseudonymous collection of data from medical reports of patients treated, over the period 2015-2022, in each intensive care unit agreeing to participate, .
Investigators from each participating center will be responsible for screening on all hospitalized patients over the period 2015-2022. Patients who have been hospitalized for the management of acute obstructive pyelonephritis will be included, in the absence of non-inclusion criteria.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 1000
- Patients over 18 years of age
- Hospitalized in intensive care for management of acute obstructive pyelonephritis
- Patients affiliated to a Social Security System
- Pregnancy
- Opposition to data use
- Persons under legal protection (curatorship, guardianship), legal safeguards
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary endpoint will be a combined endpoint of death, and/or stage 3 AKI ( KDIGO classification), and/or non-recovery of renal function. up to 30 days after admission to intensive care
- Secondary Outcome Measures
Name Time Method the incidence of acute renal failure defined by KDIGO 2 and 3 up to 30 days after admission to intensive care the incidence of Renal replacement therapy up to 30 days after admission to intensive care The number of days alive without Renal replacement therapy up to 30 days after admission to intensive care the incidence of non-recovery of renal fuction up to 30 days after admission to intensive care The number of days alive without antibiotics up to 30 days after admission to intensive care Death up to 30 days after admission to intensive care Stage 3 Acute kidney injury (KDIGO classification) up to 30 days after admission to intensive care failure to recover renal function up to 30 days after admission to intensive care . defined as creatinine levels greater than 150% of baseline value
the incidence of acute renal failure defined by KDIGO 1 up to 30 days after admission to intensive care The number of days alive without catecholamines up to 30 days after admission to intensive care The number of days alive without up to 30 days after admission to intensive care Death rate up to 30 days after admission to intensive care
Trial Locations
- Locations (1)
Hospital Saint Louis
🇫🇷Paris, France